Structure Therapeutics (GPCR) Accumulated Depreciation (2022 - 2025)

Structure Therapeutics' Accumulated Depreciation history runs 4 years deep, the most recent figure standing at $3.0 million for Q4 2025.

• In Q4 2025, Accumulated Depreciation rose 81.48% year-over-year to $3.0 million; the TTM figure through Dec 2025 stood at $3.0 million (up 81.48% YoY), while the FY2025 annual figure was $3.0 million, up 81.48% from the prior year.
• Accumulated Depreciation was $3.0 million for Q4 2025 at Structure Therapeutics, up from $1.6 million in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $3.0 million in Q4 2025 to a low of $349000.0 in Q4 2022.
• Historically, Accumulated Depreciation has averaged $1.0 million across 4 years, with a median of $755000.0 in 2023.
• The sharpest annual moves came in 2024 and 2025: Accumulated Depreciation jumped 154.04% in 2024, then surged 81.48% in 2025.
• A 4-year view of Accumulated Depreciation shows it stood at $349000.0 in 2022, then surged by 84.53% to $644000.0 in 2023, then jumped by 154.04% to $1.6 million in 2024, then soared by 81.48% to $3.0 million in 2025.
• The last three Accumulated Depreciation figures came in at $3.0 million (Q4 2025), $1.6 million (Q4 2024), and $1.4 million (Q3 2024), per Business Quant data.